Supernus Pharmaceuticals, Inc. (SUPN)
56.01
+1.45
(+2.66%)
USD |
NASDAQ |
Mar 04, 11:43
Supernus Pharmaceuticals Research and Development Expense (Annual) : 106.24M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.481B |
| BridgeBio Pharma, Inc. | 451.95M |
| Corcept Therapeutics, Inc. | 254.91M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Cytokinetics, Inc. | 405.90M |